Conquer Myasthenia Gravis is a not-for-profit 501(c)3 organization that receives funding from both individuals and corporate partners. By working together, we are able to raise awareness about myasthenia, and fund Conquer MG’s services and programs for MG patients.
A partnership with Conquer MG can help a business improve visibility and have a positive social impact. Conquer MG works with each corporation to create a customized partnership. We strive to build strong and lasting relationships, and to provide value back to the corporation.
2026 Corporate Sponsors
The biotechnology company argenx is translating immunology breakthroughs into differentiated medicines. Argenx supports Conquer MG efforts in patient education, awareness, and events that bring the MG community together such as support groups and our Viking Challenge for MG. 
Alexion is at the forefront of developing therapies for the treatment of MG, with some already FDA-approved. Alexion sponsors Conquer MG efforts to educate patients, raise awareness about myasthenia, and promote initiatives for the MG community. Visit the Conquer MG Partner Page to view patient resources [HERE].
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.
Catalyst Pharmaceuticals is committed to developing and delivering innovative therapies for people living with rare diseases, including neuromuscular disorders such as myasthenia gravis. Catalyst supports Conquer MG’s mission to educate patients, raise awareness, and strengthen the MG community through programs, events, and patient resources.
Johnson & Johnson works to advance healthcare innovation through research, development, and collaboration across a wide range of diseases and conditions. Johnson & Johnson supports Conquer MG’s efforts to provide education, foster community connections, and empower individuals living with myasthenia gravis and their families.
UCB is a global biopharmaceutical company focused on developing innovative medicines for people living with severe neurological and immunological diseases, including myasthenia gravis. UCB supports Conquer MG’s work to educate patients, increase awareness, and bring the MG community together through programs, support groups, and outreach initiatives.
Affiliations
The MG Alliance unites nonprofit organizations dedicated to supporting the myasthenia gravis (MG) community. Together, they raise awareness, provide education, and offer resources through programs and collaborative initiatives. By connecting and empowering those affected by MG, the Alliance creates an inclusive network committed to improving lives and advancing advocacy nationwide.
